Related Experiment Video
Updated: Jun 20, 2026
Assessment of the Metabolic Profile of Primary Leukemia Cells
Published on: November 21, 2018
[A clinical and therapeutic analysis in acute megakaryoblastic leukemia]
José Luis Delgado-Lamas1, Oscar Miguel Garcés-Ruiz, Lilia Beatriz Aguilar-López
1Servicio de Hematología, Hospital de Especialidades, Centro Médico Nacional de Occidente, Guadalajara Instituto Mexicano del Seguro Social, Jalisco, Mexico. delgado_lamas2002@hotmail.com
Objective:
to show clinical and therapeutic findings in patients with diagnosis of acute megakaryoblastic leukemia (AML).
Methods:
twenty four patients with diagnosis AML was carried out. Clinical, laboratory survey results and treatment response were studied. Nineteen patients had primary form and five secondary, attended during a period of eight years. The diagnosis was established by a highly clinical suspicious, with immunophenotype cytometry flow or/and bone biopsy with immunohistochemistry study which proves definitely AML.
Results:
Fourteen were women, the median age was 43 years, 18 were treated with antineoplasic agents, ten obtained response, six complete and four partial. The response may improve with schemes with high dose of cytosine arabinoside.
Conclusions:
our results with the treatment showed that 27 % patients are alive under maintenance treatment long 18 months. The allogeneic bone marrow transplant seems to be one more option in long term.
More Related Videos
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018